1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Larotrectinib
Trade Name:
Vitrakvi
Manufacturer/Distributor:
Bayer Inc.
Classification:
Antineoplastic agent
ATC Class:
L01EX12 - larotrectinib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/07/04
Date Marketed in Canada (yyyy/mm/dd):
2019/07/10
Presentation:
Capsule: 25 mg. DIN: 02490315
Capsule: 100 mg. DIN: 024190323
Oral solution: 20 mg/mL. DIN: 02490331
Comments:
NOC/c - for treatment of adults and children with solid tumors (see product monograph for specifics).
Back to:
Drug Product Listings 
